Delivery Order SPE2DB20D2001-SPE2DB25FPNNE
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This contract, valued at $23,775.26, represents a firm fixed price delivery order with a completion date of June 2, 2025. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement standards through open competition. The...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram format, with a ceiling value of $2,046.89. This competitively awarded, firm fixed-price contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order carries...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a contract ceiling value of $1,310.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Opzelura 1.5% cream in 60-gram units, valued at $22,363.62. This firm fixed price delivery order, with an ultimate completion date of November 12, 2024, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Opzelura 1.5% cream in a 60-gram unit, with a ceiling value of $1,310.45. This competitively awarded, firm fixed-price delivery order is set to be completed by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram formulation, with a contract ceiling value of $3,965.99. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, representing a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. No set-aside designation was used in this competitive award, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a ceiling value of $6,776.02 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- This delivery order, awarded on July 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Opzelura 1.5% Cream in 60-gram units with a ceiling value of $1,310.45. The award represents a firm fixed-price delivery order under a non-competitive, non-set-aside procurement, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNNEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $5,766.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery represents a routine pharmaceutical supply transaction within AmerisourceBergen's extensive federal medical procurement portfolio. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for military and federal healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's ongoing federal contract awards demonstrate its capability to supply a diverse range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/21/25 |